UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 119 filers reported holding UNIQURE NV in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,004 | -13.8% | 224 | 0.0% | 0.00% | – |
| Q1 2024 | $1,165 | -23.2% | 224 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $1,516 | +0.9% | 224 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,503 | -41.4% | 224 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,567 | +135.9% | 224 | +314.8% | 0.00% | 0.0% |
| Q1 2023 | $1,088 | -11.1% | 54 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,224 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
| Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
| Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
| Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
| Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
| 683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
| PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
| Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
| Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |